The global biobanking market was valued at USD 72.1 billion in 2024, with Europe holding a significant market share. The market is primarily driven by increasing investments in biomedical research, advancements in genomics, and the growing need for large-scale biological sample collections to support drug development and personalized medicine. With the demand for high-quality biological samples...